R&D/Clinical Trials

Latest News

Bristol Myers Squibb Reveals Promising Results from Trial of Zeposia for Multiple Sclerosis
Bristol Myers Squibb Reveals Promising Results from Trial of Zeposia for Multiple Sclerosis

March 1st 2024

Phase III DAYBREAK study found consistent safety with Zeposia in patients with relapsing forms of multiple sclerosis.

Simon Bruce
The State of Obesity-Related Clinical Research: Q&A with Simon Bruce, Vice President, Internal Medicine, Drug Development Solutions, ICON

March 1st 2024

Image credit: stock_acc | stock.adobe.com. Blood cancer cells under the microscope close up macro
Indapta Therapeutics Granted FDA Fast Track Designation for Natural Killer Cell Therapy for Hematologic Malignancies

February 29th 2024

Image credit: jarun011 | stock.adobe.com. Blood sample positive with respiratory syncytial virus (RSV)
Pfizer’s Bivalent Respiratory Syncytial Virus Vaccine Shows Promising Efficacy Across Two Seasons

February 29th 2024

Viking Therapeutics’ GLP-1/GIP Receptor Agonist Shows Positive Results in Obesity Clinical Trial
Viking Therapeutics’ GLP-1/GIP Receptor Agonist Shows Positive Results in Obesity Clinical Trial

February 28th 2024

More News